Onesource Specialty Pharma Stock

Onesource Specialty Pharma P/B

The P/B (Price-to-Book Ratio) of Onesource Specialty Pharma (ONESOURCE.NS) as of Sep 4, 2026 is 2.32. In the previous year, P/B (Price-to-Book Ratio) was 34.54 — a change of -93.27% (lower).

P/B

2.32

YoY

-93.27%

Last updated:

P/B (Price-to-Book Ratio) of Onesource Specialty Pharma is 2026 2.32 . P/B (Price-to-Book Ratio) of Onesource Specialty Pharma was 2025 34.54 . It decreases by -93.27% lower compared to the previous year.

The Onesource Specialty Pharma P/B history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

P/B
Date
P/B
Jan 1, 2023
17.40 INR
Jan 1, 2024
34.54 INR
Jan 1, 2025
2.32 INR
The Onesource Specialty Pharma P/B history
YEARP/BYoY
2.32-93.27%
34.54+98.49%
17.40
Access this data via the Eulerpool API

Onesource Specialty Pharma Stock analysis

What does Onesource Specialty Pharma do? Onesource Specialty Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Onesource Specialty Pharma stock

P/B (Price-to-Book Ratio) of Onesource Specialty Pharma is 2.32 in 2026.

P/B (Price-to-Book Ratio) of Onesource Specialty Pharma changed from 34.54 to 2.32, representing a -93.27% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Onesource Specialty Pharma since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Onesource Specialty Pharma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Onesource Specialty Pharma

All Key Metrics — Onesource Specialty Pharma